AREVF OTC
AREV Life Sciences Global Corp
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -95.0%
3Y: -99.7%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$284K
+80.7% ▲
Capital Expenditures
$82K
-579.6% ▼
5Y CAGR: -6.3%
Free Cash Flow
-$366K
+75.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$158K
-13.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$3M | -$1M | -$990K | -$1M |
| Depreciation & Amort. | $52K | $66K | $149K | $146K | $126K |
| Stock-Based Comp. | $617K | $1M | $106K | $455K | $144K |
| Change in Working Capital | -$203K | $620K | $424K | -$370K | $850K |
| Other Non-Cash Items | $36K | $1M | $67K | $97K | $40K |
| Operating Cash Flow | -$1M | -$114K | -$24K | -$1M | -$284K |
| — Investing Activities — | |||||
| Capital Expenditures | -$50K | -$215K | -$456K | -$66K | -$27K |
| Acquisitions (Net) | $29K | $0 | $20K | $60K | $0 |
| Investment Purchases | $0 | $0 | $75K | $0 | $0 |
| Investment Sales | $0 | $0 | $20K | $0 | $0 |
| Other Investing | -$406K | $0 | -$95K | $11K | -$55K |
| Investing Cash Flow | -$428K | -$215K | -$436K | $5K | -$82K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $100K | -$53K | $314K | $5K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $630K | $0 | $330K | $303K | $202K |
| Financing Cash Flow | $630K | $350K | $728K | $1M | $208K |
| Net Change in Cash | -$1M | $21K | $268K | -$139K | -$158K |
| Cash End of Period | $8K | $30K | $298K | $158K | $94 |
| Free Cash Flow | -$1M | -$329K | -$480K | -$1M | -$366K |